Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Price:
41.11 USD
0.69%
Market Closed
Updated:
Apr 29, 2024
Amphastar Pharmaceuticals Inc
Operating Income
|
Amphastar Pharmaceuticals Inc
Operating Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Operating Income
$199.7m
|
CAGR 3-Years
163%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
27%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Income
$23.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Income
$10.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Income
$13.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Income
$4.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Income
$10.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
See Also
What is Amphastar Pharmaceuticals Inc's Operating Income?
Operating Income
199.7m
USD
199.7m
USD
Based on the financial report for Dec 31, 2023, Amphastar Pharmaceuticals Inc's Operating Income amounts to 199.7m USD.
What is Amphastar Pharmaceuticals Inc's Operating Income growth rate?
Operating Income CAGR 10Y
27%
27%
Over the last year, the Operating Income growth was 86%. The average annual Operating Income growth rates for Amphastar Pharmaceuticals Inc have been 163% over the past three years , and 27% over the past ten years .
You don't have any saved screeners yet
